About the Company
AMAG Pharmaceuticals, Inc. is a biopharmaceutical company. It focuses on the manufacture, development, and commercialization of a therapeutic iron compound to treat iron deficiency anemia. The firm focuses on the development and commercialization of Feraheme injection for intravenous use to treat iron deficiency anemia. It manufactures, develops, and commercializes products derived from its proprietary technology for use in treating human diseases. Its products include Intrarosa, Vyleesi, Makena, CBR, Feraheme, and MuGard. The company was founded on November 9, 1981 and is headquartered in Waltham, MA.
Fundamental Data and Insider Transactions (Quarterly data) Full Screen
Loading the fundamentals chart...
Latest $AMAG News
AMAG Pharmaceuticals gets grant for microchip for measuring clotting time in blood samples
Measure clotting times in blood samples with AMAG Pharmaceuticals' innovative microfluidic chip-based assay device. Patent US11852639B2 discloses a precise and reproducible method using anionically ...
Amag Pharmaceuticals
METHODOLOGY: The numbers on this page are based on contributions from PACs and individuals giving $200 or more. All donations were made during the 2024 election cycle and were released by the Federal ...
Activist Fund Manager Ups Stake in Amag Pharma to Stop Merger With Allos
Hedge fund manager Martin Shkreli now own 5% of Amag and is seeking to replace directors to stop a planned merger with Allos Therapeutics. Hedge fund manager Martin Shkreli now own 5% of Amag and ...
Contact AMAG Technology, Inc.
AMAG Technology is a provider of fully integrated security solutions throughout the world, protecting everything from small offices and schools to large multi-national organizations and high security ...
AMAG Technology Introduces Symmetry Control Room
HAWTHORNE, CA / ACCESSWIRE / April 9, 2024 / AMAG Technology™, an Allied Universal Company®, is proud to announce Symmetry™ ...
Guardant Health Inc (GH)
AMAG Pharmaceuticals, Inc. (NASDAQ:AMAG) incurred a loss of $1.28 per share in the second quarter of 2019, much wider than the Zacks Consensus Estimate of a loss of 66 cents as ...
RCKT Rocket Pharmaceuticals, Inc.
Rocket Pharmaceuticals, Inc., together with its subsidiaries, operates as a late-stage biotechnology company that focuses on developing gene therapies for rare and devastating diseases.
CRVS Corvus Pharmaceuticals, Inc.
Corvus Pharmaceuticals, Inc., a clinical stage biopharmaceutical company, focuses on the development and commercialization of immune modulator product candidates to treat solid cancers ...
Madrigal Pharmaceuticals, Inc. (MDGL)
CONSHOHOCKEN, Pa., April 23, 2024 (GLOBE NEWSWIRE) -- Madrigal Pharmaceuticals, Inc. (Nasdaq: MDGL) announced today that it will release its first-quarter 2024 financial results on Tuesday ...
ANI Pharmaceuticals Inc ANIP
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings ...
Longboard Pharmaceuticals, Inc. (NASDAQ:LBPH) is a favorite amongst institutional investors who own 50%
Significantly high institutional ownership implies Longboard Pharmaceuticals' stock price ... Every investor in Longboard Pharmaceuticals, Inc. (NASDAQ:LBPH) should be aware of the most powerful ...
Vertex Pharmaceuticals Inc VRTX
We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...
Loading the latest forecasts...